IFM Investors Pty Ltd Has $1.13 Million Stock Holdings in Varian Medical Systems, Inc. (NYSE:VAR)

IFM Investors Pty Ltd lifted its holdings in Varian Medical Systems, Inc. (NYSE:VAR) by 35.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 9,461 shares of the medical equipment provider’s stock after buying an additional 2,478 shares during the period. IFM Investors Pty Ltd’s holdings in Varian Medical Systems were worth $1,127,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of VAR. Nuveen Asset Management LLC boosted its position in shares of Varian Medical Systems by 14,499.7% in the second quarter. Nuveen Asset Management LLC now owns 378,862 shares of the medical equipment provider’s stock worth $51,574,000 after buying an additional 376,267 shares during the period. BlackRock Inc. boosted its position in shares of Varian Medical Systems by 4.0% in the second quarter. BlackRock Inc. now owns 8,316,444 shares of the medical equipment provider’s stock worth $1,132,117,000 after buying an additional 319,325 shares during the period. Wells Fargo & Company MN boosted its position in shares of Varian Medical Systems by 19.7% in the second quarter. Wells Fargo & Company MN now owns 1,889,170 shares of the medical equipment provider’s stock worth $257,171,000 after buying an additional 311,004 shares during the period. Boston Trust Walden Corp boosted its position in shares of Varian Medical Systems by 113.5% in the third quarter. Boston Trust Walden Corp now owns 455,342 shares of the medical equipment provider’s stock worth $54,226,000 after buying an additional 242,080 shares during the period. Finally, Invesco Ltd. boosted its position in shares of Varian Medical Systems by 42.1% in the second quarter. Invesco Ltd. now owns 702,878 shares of the medical equipment provider’s stock worth $95,683,000 after buying an additional 208,094 shares during the period. 91.48% of the stock is owned by institutional investors and hedge funds.

In related news, SVP John W. Kuo sold 465 shares of Varian Medical Systems stock in a transaction on Monday, September 16th. The stock was sold at an average price of $116.30, for a total transaction of $54,079.50. Following the completion of the sale, the senior vice president now owns 35,411 shares of the company’s stock, valued at $4,118,299.30. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In the last three months, insiders have sold 1,395 shares of company stock valued at $158,388. Insiders own 0.78% of the company’s stock.

VAR traded up $1.30 during trading on Friday, reaching $124.76. 488,581 shares of the stock traded hands, compared to its average volume of 665,692. The stock has a market cap of $11.27 billion, a price-to-earnings ratio of 26.95, a price-to-earnings-growth ratio of 2.87 and a beta of 0.87. Varian Medical Systems, Inc. has a fifty-two week low of $103.92 and a fifty-two week high of $142.50. The stock’s 50-day simple moving average is $117.33 and its two-hundred day simple moving average is $123.18.

Varian Medical Systems (NYSE:VAR) last released its quarterly earnings data on Wednesday, October 23rd. The medical equipment provider reported $1.21 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.21. The firm had revenue of $878.90 million during the quarter, compared to analysts’ expectations of $858.47 million. Varian Medical Systems had a return on equity of 24.42% and a net margin of 9.65%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.16 earnings per share. On average, equities research analysts expect that Varian Medical Systems, Inc. will post 5.39 EPS for the current year.

Several analysts have recently commented on VAR shares. Zacks Investment Research cut Varian Medical Systems from a “strong-buy” rating to a “hold” rating and set a $139.00 target price for the company. in a research report on Saturday, July 27th. Barrington Research raised their target price on Varian Medical Systems from $146.00 to $152.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. ValuEngine cut Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Tuesday, August 20th. BTIG Research raised Varian Medical Systems from a “neutral” rating to a “buy” rating and set a $130.00 price objective for the company in a research report on Monday, October 14th. Finally, Robert W. Baird set a $158.00 price objective on Varian Medical Systems and gave the company a “buy” rating in a research report on Friday, July 26th. Three analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Varian Medical Systems currently has an average rating of “Buy” and an average target price of $145.11.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through two segments, Oncology Systems and Proton Solutions. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, and brachytherapy, as well as related quality assurance equipment.

Recommended Story: Why is a lock-up period needed for an IPO?

Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply